Citation:Selvadurai ED, Singhera M, Thomas K, Mohammed K, Woode-Amissah R, Horwich A, et al 2013

Citation

Selvadurai ED, Singhera M, Thomas K, Mohammed K, Woode-Amissah R, Horwich A, et al. Medium-term outcomes of active surveillance for localised prostate cancer. Eur Urol 2013 Dec;64(6):981-7 Available from: http://www.ncbi.nlm.nih.gov/pubmed/23473579.

Critical appraisals

• Assign a critical appraisal

Critical appraisal link	Clinical question	Assigned to	Status
Selvadurai ED, Singhera M, Thomas K, Mohammed K, Woode-Amissah R, Horwich A, et al 2013	For men with biopsy-diagnosed prostate cancer, for which patients (based on diagnostic and clinical criteria) does active surveillance achieve equivalent or better outcomes in terms of length and quality of life than definitive treatment?	Katherine Sheridan	completed
Selvadurai ED, Singhera M, Thomas K, Mohammed K, Woode-Amissah R, Horwich A, et al 2013 2	For men with biopsy-diagnosed prostate cancer, for which patients (based on diagnostic and clinical criteria) does active surveillance achieve equivalent or better outcomes in terms of length and quality of life than definitive treatment?	Dr Albert Chetcuti BTech(Biotech) Hons, PhD	completed

Compare quality appraisals for each clinical question

• [[Clinical question:For men with biopsy-diagnosed prostate cancer, for which patients does active surveillance achieve equivalent or better outcomes in terms of length and quality of life than definitive treatment?|]] (compare critical appraisals)
• [[Clinical question:For men with biopsy-diagnosed prostate cancer, for which patients does active surveillance achieve equivalent or better outcomes in terms of length and quality of life than definitive treatment?|]] (compare critical appraisals)

Cited by

1. Active surveillance